tiprankstipranks
Trending News
More News >
Tourmaline Bio, Inc. (TRML)
:TRML
US Market

Tourmaline Bio (TRML) Income Statement

Compare
568 Followers

Tourmaline Bio Income Statement

Last quarter (Q2 2025), Tourmaline Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Tourmaline Bio's net income was $-23.09M. See Tourmaline Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -39.00K$ -33.00K$ -6.00K$ -623.00K$ -447.00K
Operating Expenses
$ 89.73M$ 45.41M$ 19.70M$ 46.88M$ 22.24M
Depreciation and Amortization
$ -16.52M$ 33.00K$ 6.00K$ 623.00K$ 447.00K
EBITDA
$ -89.73M$ -45.38M$ -19.70M$ -46.88M$ -22.24M
Operating Income
$ -89.73M$ -45.41M$ -19.70M$ -47.51M$ -22.68M
Other Income/Expenses
$ 16.52M$ 3.29M$ 0.00$ -326.00K$ -23.00K
Pretax Income
$ -73.21M$ -42.12M$ -19.70M$ -47.83M$ -22.71M
Net Income
$ -73.21M$ -42.12M$ -19.70M$ -904.00$ -22.71M
Per Share Metrics
Basic EPS
$ -2.89$ -8.87$ -0.97$ 0.00$ -33.97
Diluted EPS
$ -2.89$ -8.87$ -0.97$ 0.00$ -33.97
Weighted Average Shares Outstanding
25.35M 4.75M 20.34M 10.88M 668.51K
Weighted Average Shares Outstanding (Diluted)
25.35M 4.75M 20.34M 10.88M 668.51K
Currency in USD

Tourmaline Bio Earnings and Revenue History